# Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients

> **NCT01718613** · PHASE3 · COMPLETED · sponsor: **Instituto do Cancer do Estado de São Paulo** · enrollment: 250 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Vasopressin
- **DRUG:** Norepinephrine

## Key facts

- **NCT ID:** NCT01718613
- **Lead sponsor:** Instituto do Cancer do Estado de São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2014-03
- **Final completion:** 2018-05
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2018-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01718613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01718613, "Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01718613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*